GSK Buys Asthma-Focused Aiolos
Wall Street Journal
GSK said it has bought Aiolos Bio for an upfront consideration of $1 billion, with the potential for an additional $400 million.
https://www.wsj.com/articles/gsk-buys-aiolos-bio-for-up-to-1-4-bln-4eaf44d0